The State Contingent Approach to Farmers' Valuation and Adoption of New Biotech Crops: Nitrogen-Fertilizer Saving and Drought Tolerance Traits

We used a state contingent approach to give a detailed analysis of the uncertainty surrounding seed trait adoption. Our framework emphasizes the role of timing and information in farmers’ adoption decisions. The inherent embeddedness of seed traits results in timing restrictions and the inability of post-planting adjustments, this in turn results in farmers necessarily engaging in a game with nature. Two main types of traits we identify are supplementing traits and stabilizing traits – classification into each category is directly related on the mobility of the production factor the trait intends to substitute. Supplementing traits allow for acting after nature (i.e., ex post) while stabilizing traits are better modeled as acting before nature (i.e., ex ante). The type of trait results in different determinants of the farmers’ WTP function.State Contingent, Genetically Modified, Biotech, Contingent Valuation, Nitrogen Absorption Efficiency, Drought Tolerance, Uncertainty, Seed Trait, Technological Adoption, Crop Production/Industries, Research and Development/Tech Change/Emerging Technologies,

Sistemas agroflorestais no contexto do processo da transição agroecológica.

Os sistemas agroflorestais são experiências locais que podem validar os princípios e enriquecer a própria concepção teórica de agroecologia. O resgate destas práticas tradicionais baseada na agrobiodiversidade, aliado ao conhecimento cientifico, estão sendo sistematizados para apoiar o processo de transição agroecológica. Foram implantados e avaliados quatro arranjos agroflorestais, em três condições de áreas de pastagens abandonadas, no Campo Experimental da Embrapa Amazônia Ocidental

Cardiopulmonary Resuscitation Survey: Is Blood Circulating?

Antecedentes: El protocolo actual de reanimación cardiopulmonar (RCP) se ha establecido integrando varios procesos que se han estudiado durante más de un siglo. Debido al éxito de estas maniobras, la comunidad médica considera que se debe preservar la circulación sanguínea durante la RCP. Métodos y resultados: se pidió a 202 médicos con experiencia en RCP que completaran una encuesta de dos partes para evaluar las declaraciones sobre la calidad de la RCP de la Asociación Americana del Corazón (AHA). Posteriormente, se les dio una revisión de los principios de fisiología y se les presentó la hipótesis de que es poco probable que la RCP genera una circulación sanguínea efectiva. Se pidió a los médicos que volvieran a evaluar sus respuestas anteriores después de la revisión de fisiología. Inicialmente, más del 70% de los médicos encuestados consideraban las compresiones torácicas capaces de distribuir sangre oxigenada por todo el cuerpo. Sin embargo, solo el 32,7% creía que esta afirmación era correcta después de reconsiderar conceptos clave sobre la fisiología circulatoria. Conclusión: Después de revisar los principios fisiológicos del sistema circulatorio, el 67% de 202 médicos con experiencia en RCP consideraron dudoso o falso que la sangre pueda circular durante las maniobras de RCP. El 51,5% de los médicos encuestados considera cierta la siguiente hipótesis sobre la RCP: durante las maniobras de reanimación cardiopulmonar actuales, es poco probable que la sangre circule por las cámaras del corazón, viaje al pulmón en busca de oxígeno y regrese al corazón para ser impulsada a otros órganos. como el cerebro. Es necesario extender la encuesta a un número más amplio de médicos para evaluar la consistencia de estos resultados y orientar futuras investigaciones sobre la hidrodinámica de la RCP.Background: The current protocol for cardiopulmonary resuscitation (CPR) has been established by integrating various processes studied for over a century. Due to the success of these maneuvers, the medical community believes that blood circulation should be preserved during CPR. Methods and Results: A total of 202 experienced CPR doctors were asked to complete a two-part survey to evaluate statements on CPR quality from the American Heart Association (AHA). Subsequently, they were given a review of physiological principles and presented with the hypothesis that effective blood circulation is unlikely during CPR. Doctors were asked to reevaluate their previous responses after the physiology review. Initially, over 70% of surveyed doctors considered chest compressions capable of distributing oxygenated blood throughout the body. However, only 32.7% believed this statement to be accurate after reconsidering key concepts about circulatory physiology Conclusion: After reviewing physiological principles of the circulatory system, 67% of 202 experienced CPR doctors considered it doubtful or false that blood can circulate during CPR maneuvers. 51.5% of surveyed doctors believe in the following hypothesis about CPR: during current cardiopulmonary resuscitation maneuvers, it is unlikely that blood circulates through the heart chambers, travels to the lungs for oxygen, and returns to the heart to be pumped to other organs like the brain. A broader survey among more doctors is needed to assess the consistency of these results and guide future research on the hydrodynamics of CPR

Conservation actions and ecological context: optimizing coral reef local management in the Dominican Republic

Over the past few decades, coral reef ecosystems have been lost at accelerated rates as a result of global climate change and local stressors. Local management schemes can help improve the condition of coral reefs by enhancing their ecosystem recovery capacity. Caribbean conservation efforts include mitigation of local anthropogenic stressors, and integrating social participation. Here, we analyzed the case of the Bayahibe reefs in the Southeastern (SE) Dominican Republic to identify conservation actions and illustrate a conceptual example of local seascape management. We assessed reef health indicators from 2011 to 2016. Overall, our results show increases in total fish biomass, in both commercial and herbivorous fishes. Mean live coral cover was 31% and fleshy macroalgae was 23% after multiple disturbances such as Hurricanes Sandy and Isaac (2012), Mathew (2016) and heat stress presented in the study area in 2015. We also described actions taken by stakeholders and government institutions, including the implementation of a policy declaring an area of 869,000 ha as a marine protected area (MPA), enhanced water quality treatment, local restrictions to vessel traffic, enforcement of fishing regulations, and the removal of invasive lionfish (Pterois spp.). In addition, a restoration program for the threatened staghorn coral (Acropora cervicornis) was established in 2011, and currently has eight coral nurseries and six outplanting sites. Considering the biology and ecology of these reefs, we observed good results for these indicators (live coral cover, fish biomass, and water quality) in contrast with severely degraded Caribbean reefs, suggesting that optimizing local management may be a useful example for improving reef condition. Our results provide an overview of trends in reef condition in the SE Dominican Republic and could support current strategies to better protect reefs in the region. Given that Caribbean coral reefs face extreme challenges from global climate change, management measures may improve reef conditions across the region but stronger policy processes and increased scientific knowledge are needed for the successful management of coral reefs

Alcohol-impaired Walking in 16 Countries:A Theory-Based Investigation

Alcohol is a global risk factor for road trauma. Although drink driving has received most of the scholarly attention, there is growing evidence of the risks of alcohol-impaired walking. Alcohol-impaired pedestrians are over-represented in fatal crashes compared to non-impaired pedestrians. Additionally, empirical evidence shows that alcohol intoxication impairs road-crossing judgements. Besides some limited early research, much is unknown about the global prevalence and determinants of alcohol-impaired walking. Understanding alcohol-impaired walking will support health promotion initiatives and injury prevention. The present investigation has three aims: (1) compare the prevalence of alcohol-impaired walking across countries; (2) identify international groups of pedestrians based on psychosocial factors (i.e., Theory of Planned Behaviour (TPB) and perceptions of risk); and (3) investigate how segments of pedestrians form their intention for alcohol-impaired walking using the extended TPB (i.e. subjective norm, attitudes, perceived control, and perceived risk). A cross-sectional design was applied. The target behaviour question was “have you been a pedestrian when your thinking or physical ability (balance/strength) is affected by alcohol?” to ensure comparability across countries. Cluster analysis based on the extended TPB was used to identify groups of countries. Finally, regressions were used to predict pedestrians’ intentions per group. A total of 6,166 respondents (Age M(SD) = 29.4 (14.2); Males = 39.2%) completed the questionnaire, ranging from 12.6% from Russia to 2.2% from Finland. The proportion of participants who reported never engaging in alcohol-impaired walking in the last three months ranged from 30.1% (Spain) to 83.1% (Turkey). Four groups of countries were identified: group-1 (Czech Republic, Spain, and Australia), group-2 (Russia and Finland), group-3 (Japan), and group-4 (final ten countries including Colombia, China, and Romania). Pedestrian intentions to engage in alcohol- impaired walking are predicted by perceptions of risk and TPB-psychosocial factors in group-1 and group-4. Favourable TPB-beliefs and low perceived risk increased alcohol-impaired walking intentions. Conversely, subjective norms were not significant in group-2 and only perceived risk predicted intention in group-3. The willingness of pedestrians to walk when alcohol-impaired differs significantly across the countries in this study. Perceived risk was the only common predictor among the 16 countries.</p

Assessing the format and content of journal published and non-journal published rapid review reports : A comparative study

BACKGROUND: As production of rapid reviews (RRs) increases in healthcare, knowing how to efficiently convey RR evidence to various end-users is important given they are often intended to directly inform decision-making. Little is known about how often RRs are produced in the published or unpublished domains, and what and how information is structured. OBJECTIVES: To compare and contrast report format and content features of journal-published (JP) and non-journal published (NJP) RRs. METHODS: JP RRs were identified from key databases, and NJP RRs were identified from a grey literature search of 148 RR producing organizations and were sampled proportionate to cluster size by organization and product type to match the JP RR group. We extracted and formally compared 'how' (i.e., visual arrangement) and 'what' information was presented. RESULTS: We identified 103 RRs (52 JP and 51 NJP) from 2016. A higher percentage of certain features were observed in JP RRs compared to NJP RRs (e.g., reporting authors; use of a traditional journal article structure; section headers including abstract, methods, discussion, conclusions, acknowledgments, conflict of interests, and author contributions; and use of figures (e.g., Study Flow Diagram) in the main document). For NJP RRs, a higher percentage of features were observed (e.g., use non-traditional report structures; bannering of executive summary sections and appendices; use of typographic cues; and including outcome tables). NJP RRs were more than double in length versus JP RRs. Including key messages was uncommon in both groups. CONCLUSIONS: This comparative study highlights differences between JP and NJP RRs. Both groups may benefit from better use of plain language, and more clear and concise design. Alternative innovative formats and end-user preferences for content and layout should be studied further with thought given to other considerations to ensure better packaging of RR results to facilitate uptake into policy and practice. STUDY REGISTRATION: The full protocol is available at: https://osf.io/29xvk/

Primary stroke prevention worldwide : translating evidence into action

Funding Information: The stroke services survey reported in this publication was partly supported by World Stroke Organization and Auckland University of Technology. VLF was partly supported by the grants received from the Health Research Council of New Zealand. MOO was supported by the US National Institutes of Health (SIREN U54 HG007479) under the H3Africa initiative and SIBS Genomics (R01NS107900, R01NS107900-02S1, R01NS115944-01, 3U24HG009780-03S5, and 1R01NS114045-01), Sub-Saharan Africa Conference on Stroke Conference (1R13NS115395-01A1), and Training Africans to Lead and Execute Neurological Trials & Studies (D43TW012030). AGT was supported by the Australian National Health and Medical Research Council. SLG was supported by a National Heart Foundation of Australia Future Leader Fellowship and an Australian National Health and Medical Research Council synergy grant. We thank Anita Arsovska (University Clinic of Neurology, Skopje, North Macedonia), Manoj Bohara (HAMS Hospital, Kathmandu, Nepal), Denis ?erimagi? (Poliklinika Glavi?, Dubrovnik, Croatia), Manuel Correia (Hospital de Santo Ant?nio, Porto, Portugal), Daissy Liliana Mora Cuervo (Hospital Moinhos de Vento, Porto Alegre, Brazil), Anna Cz?onkowska (Institute of Psychiatry and Neurology, Warsaw, Poland), Gloria Ekeng (Stroke Care International, Dartford, UK), Jo?o Sargento-Freitas (Centro Hospitalar e Universit?rio de Coimbra, Coimbra, Portugal), Yuriy Flomin (MC Universal Clinic Oberig, Kyiv, Ukraine), Mehari Gebreyohanns (UT Southwestern Medical Centre, Dallas, TX, USA), Ivete Pillo Gon?alves (Hospital S?o Jos? do Avai, Itaperuna, Brazil), Claiborne Johnston (Dell Medical School, University of Texas, Austin, TX, USA), Kristaps Jurj?ns (P Stradins Clinical University Hospital, Riga, Latvia), Rizwan Kalani (University of Washington, Seattle, WA, USA), Grzegorz Kozera (Medical University of Gda?sk, Gda?sk, Poland), Kursad Kutluk (Dokuz Eylul University, ?zmir, Turkey), Branko Malojcic (University Hospital Centre Zagreb, Zagreb, Croatia), Micha? Maluchnik (Ministry of Health, Warsaw, Poland), Evija Migl?ne (P Stradins Clinical University Hospital, Riga, Latvia), Cassandra Ocampo (University of Botswana, Princess Marina Hospital, Botswana), Louise Shaw (Royal United Hospitals Bath NHS Foundation Trust, Bath, UK), Lekhjung Thapa (Upendra Devkota Memorial-National Institute of Neurological and Allied Sciences, Kathmandu, Nepal), Bogdan Wojtyniak (National Institute of Public Health, Warsaw, Poland), Jie Yang (First Affiliated Hospital of Chengdu Medical College, Chengdu, China), and Tomasz Zdrojewski (Medical University of Gda?sk, Gda?sk, Poland) for their comments on early draft of the manuscript. The views expressed in this article are solely the responsibility of the authors and they do not necessarily reflect the views, decisions, or policies of the institution with which they are affiliated. We thank WSO for funding. The funder had no role in the design, data collection, analysis and interpretation of the study results, writing of the report, or the decision to submit the study results for publication. Funding Information: The stroke services survey reported in this publication was partly supported by World Stroke Organization and Auckland University of Technology. VLF was partly supported by the grants received from the Health Research Council of New Zealand. MOO was supported by the US National Institutes of Health (SIREN U54 HG007479) under the H3Africa initiative and SIBS Genomics (R01NS107900, R01NS107900-02S1, R01NS115944-01, 3U24HG009780-03S5, and 1R01NS114045-01), Sub-Saharan Africa Conference on Stroke Conference (1R13NS115395-01A1), and Training Africans to Lead and Execute Neurological Trials & Studies (D43TW012030). AGT was supported by the Australian National Health and Medical Research Council. SLG was supported by a National Heart Foundation of Australia Future Leader Fellowship and an Australian National Health and Medical Research Council synergy grant. We thank Anita Arsovska (University Clinic of Neurology, Skopje, North Macedonia), Manoj Bohara (HAMS Hospital, Kathmandu, Nepal), Denis Čerimagić (Poliklinika Glavić, Dubrovnik, Croatia), Manuel Correia (Hospital de Santo António, Porto, Portugal), Daissy Liliana Mora Cuervo (Hospital Moinhos de Vento, Porto Alegre, Brazil), Anna Członkowska (Institute of Psychiatry and Neurology, Warsaw, Poland), Gloria Ekeng (Stroke Care International, Dartford, UK), João Sargento-Freitas (Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal), Yuriy Flomin (MC Universal Clinic Oberig, Kyiv, Ukraine), Mehari Gebreyohanns (UT Southwestern Medical Centre, Dallas, TX, USA), Ivete Pillo Gonçalves (Hospital São José do Avai, Itaperuna, Brazil), Claiborne Johnston (Dell Medical School, University of Texas, Austin, TX, USA), Kristaps Jurjāns (P Stradins Clinical University Hospital, Riga, Latvia), Rizwan Kalani (University of Washington, Seattle, WA, USA), Grzegorz Kozera (Medical University of Gdańsk, Gdańsk, Poland), Kursad Kutluk (Dokuz Eylul University, İzmir, Turkey), Branko Malojcic (University Hospital Centre Zagreb, Zagreb, Croatia), Michał Maluchnik (Ministry of Health, Warsaw, Poland), Evija Miglāne (P Stradins Clinical University Hospital, Riga, Latvia), Cassandra Ocampo (University of Botswana, Princess Marina Hospital, Botswana), Louise Shaw (Royal United Hospitals Bath NHS Foundation Trust, Bath, UK), Lekhjung Thapa (Upendra Devkota Memorial-National Institute of Neurological and Allied Sciences, Kathmandu, Nepal), Bogdan Wojtyniak (National Institute of Public Health, Warsaw, Poland), Jie Yang (First Affiliated Hospital of Chengdu Medical College, Chengdu, China), and Tomasz Zdrojewski (Medical University of Gdańsk, Gdańsk, Poland) for their comments on early draft of the manuscript. The views expressed in this article are solely the responsibility of the authors and they do not necessarily reflect the views, decisions, or policies of the institution with which they are affiliated. We thank WSO for funding. The funder had no role in the design, data collection, analysis and interpretation of the study results, writing of the report, or the decision to submit the study results for publication. Funding Information: VLF declares that the PreventS web app and Stroke Riskometer app are owned and copyrighted by Auckland University of Technology; has received grants from the Brain Research New Zealand Centre of Research Excellence (16/STH/36), Australian National Health and Medical Research Council (NHMRC; APP1182071), and World Stroke Organization (WSO); is an executive committee member of WSO, honorary medical director of Stroke Central New Zealand, and CEO of New Zealand Stroke Education charitable Trust. AGT declares funding from NHMRC (GNT1042600, GNT1122455, GNT1171966, GNT1143155, and GNT1182017), Stroke Foundation Australia (SG1807), and Heart Foundation Australia (VG102282); and board membership of the Stroke Foundation (Australia). SLG is funded by the National Health Foundation of Australia (Future Leader Fellowship 102061) and NHMRC (GNT1182071, GNT1143155, and GNT1128373). RM is supported by the Implementation Research Network in Stroke Care Quality of the European Cooperation in Science and Technology (project CA18118) and by the IRIS-TEPUS project from the inter-excellence inter-cost programme of the Ministry of Education, Youth and Sports of the Czech Republic (project LTC20051). BN declares receiving fees for data management committee work for SOCRATES and THALES trials for AstraZeneca and fees for data management committee work for NAVIGATE-ESUS trial from Bayer. All other authors declare no competing interests. Publisher Copyright: © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licenseStroke is the second leading cause of death and the third leading cause of disability worldwide and its burden is increasing rapidly in low-income and middle-income countries, many of which are unable to face the challenges it imposes. In this Health Policy paper on primary stroke prevention, we provide an overview of the current situation regarding primary prevention services, estimate the cost of stroke and stroke prevention, and identify deficiencies in existing guidelines and gaps in primary prevention. We also offer a set of pragmatic solutions for implementation of primary stroke prevention, with an emphasis on the role of governments and population-wide strategies, including task-shifting and sharing and health system re-engineering. Implementation of primary stroke prevention involves patients, health professionals, funders, policy makers, implementation partners, and the entire population along the life course.publishersversionPeer reviewe